Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen
Shoichiro Tsuji, Lucas Stein, Nobuhiko Kamada, Gabriel Nuñez, Richard Bram, Bruce A. Vallance, Ana E. Sousa, Jeffrey L. Platt, Marilia Cascalho
Shoichiro Tsuji, Lucas Stein, Nobuhiko Kamada, Gabriel Nuñez, Richard Bram, Bruce A. Vallance, Ana E. Sousa, Jeffrey L. Platt, Marilia Cascalho
View: Text | PDF
Research Article Immunology

TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen

  • Text
  • PDF
Abstract

The transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) controls differentiation of long-lived plasma cells, and almost 10% of individuals with common variable immunodeficiency (CVID) express either the C104R or A181E variants of TACI. These variants impair TACI function, and TACI-deficient mice exhibit a CVID-like disease. However, 1%–2% of normal individuals harbor the C140R or A181E TACI variants and have no outward signs of CVID, and it is not clear why TACI deficiency in this group does not cause disease. Here, we determined that TACI-deficient mice have low baseline levels of Ig in the blood but retain the ability to mutate Ig-associated genes that encode antigen-specific antibodies. The antigen-specific antibodies in TACI-deficient mice were produced in bursts and had higher avidity than those of WT animals. Moreover, mice lacking TACI were able to clear Citrobacter rodentium, a model pathogen for severe human enteritis, more rapidly than did WT mice. These findings suggest that the high prevalence of TACI deficiency in humans might reflect enhanced host defense against enteritis, which is more severe in those with acquired or inherited immunodeficiencies.

Authors

Shoichiro Tsuji, Lucas Stein, Nobuhiko Kamada, Gabriel Nuñez, Richard Bram, Bruce A. Vallance, Ana E. Sousa, Jeffrey L. Platt, Marilia Cascalho

×

Figure 1

Impact of TACI deficiency on affinity maturation of antibodies produced in response to immunization.

Options: View larger image (or click on image) Download as PowerPoint
Impact of TACI deficiency on affinity maturation of antibodies produced ...
(A) KD of mAbs generated from WT and TACI-deficient mice. KD (y axis) in nM (the reciprocal of avidity is depicted in blue) of monoclonal anti-NP antibodies (mAbs) encoded by the canonical VH1-72 (VH186.2) was determined by ascertaining the concentration at equilibrium at which one-half was bound and one-half unbound (25, 45). mAbs from WT mice had an average KD of 4.6 × 10–10, while mAbs from TACI-deficient mice had an average KD of 2.4 × 10–10 (P = 0.0079, unpaired t test). (B) Comparison of mAb KD determined by real-time measurement of association and dissociation rates and BLI, with KD determined at equilibrium by ELISA. (C) Impact of TACI on the mutation frequency of VH1-72 encoded by anti-NP antibodies. Frequency of sequences with a given number of mutations is plotted. TACI deficiency increased the frequency of independent mutations by more than 2-fold (P < 0.001, contingency analysis). (D) Relationship between frequency of mutations and antibody avidity in response to NP. Frequency of mutations in VH1-72 sequences is depicted in relation to avidity at equilibrium of the corresponding antibodies. Avidity correlated with the number of mutations (P < 0.0001, Wilcoxon matched-pairs, signed-rank test). (E) Localization of aa substitutions in distinct clones encoding VH1-72 heavy chains of anti-NP antibodies obtained from WT and TACI-deficient mice. KD for the corresponding sequences was determined by BLI (values are shown on the right). V(D)J, variable(V), diversity (D) and joining (J) gene segments junction region of the Ig heavy chain exon.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts